Search Results - "Van de Voorde, Hendrik"

Molecular diagnostics for congenital hearing loss including 15 deafness genes using a next generation sequencing platform by De Keulenaer, Sarah, Hellemans, Jan, Lefever, Steve, Renard, Jean-Pierre, De Schrijver, Joachim, Van de Voorde, Hendrik, Tabatabaiefar, Mohammad Amin, Van Nieuwerburgh, Filip, Flamez, Daisy, Pattyn, Filip, Scharlaken, Bieke, Deforce, Dieter, Bekaert, Sofie, Van Criekinge, Wim, Vandesompele, Jo, Van Camp, Guy, Coucke, Paul

“…Hereditary hearing loss (HL) can originate from mutations in one of many genes involved in the complex process of hearing. Identification of the genetic…”
Get full text

Epigenetic markers in circulating cell‐free DNA as prognostic markers for survival of castration‐resistant prostate cancer patients by Hendriks, Rianne J., Dijkstra, Siebren, Smit, Frank P., Vandersmissen, Johan, Van de Voorde, Hendrik, Mulders, Peter F. A., van Oort, Inge M., Van Criekinge, Wim, Schalken, Jack A.

“…Background : Noninvasive biomarkers to guide personalized treatment for castration‐resistant prostate cancer (CRPC) are needed. In this study, we analyzed…”
Get full text

Spectral Prediction Features as a Solution for the Search Space Size Problem in Proteogenomics by Verbruggen, Steven, Gessulat, Siegfried, Gabriels, Ralf, Matsaroki, Anna, Van de Voorde, Hendrik, Kuster, Bernhard, Degroeve, Sven, Martens, Lennart, Van Criekinge, Wim, Wilhelm, Mathias, Menschaert, Gerben

“…Proteogenomics approaches often struggle with the distinction between true and false peptide-to-spectrum matches as the database size enlarges. However,…”
Get full text

Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys-Dietz syndromes by Baetens, Machteld, Van Laer, Lut, De Leeneer, Kim, Hellemans, Jan, De Schrijver, Joachim, Van De Voorde, Hendrik, Renard, Marjolijn, Dietz, Hal, Lacro, Ronald V., Menten, Björn, Van Criekinge, Wim, De Backer, Julie, De Paepe, Anne, Loeys, Bart, Coucke, Paul J.

“…The Marfan (MFS) and Loeys‐Dietz (LDS) syndromes are caused by mutations in the fibrillin‐1 (FBN1) and Transforming Growth Factor Beta Receptor 1 and 2 (TGFBR1…”
Get full text